Vital Farms (NASDAQ:VITL - Get Free Report) issued its quarterly earnings data on Thursday. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.27 by $0.09, Zacks reports. The firm had revenue of $184.77 million for the quarter, compared to analysts' expectations of $170.28 million. Vital Farms had a net margin of 7.84% and a return on equity of 19.06%. The company's quarterly revenue was up 25.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.36 earnings per share. Vital Farms updated its FY 2025 guidance to EPS.
Vital Farms Price Performance
Shares of VITL traded up $1.62 during mid-day trading on Friday, hitting $45.48. 2,161,559 shares of the company traded hands, compared to its average volume of 895,316. Vital Farms has a one year low of $27.91 and a one year high of $46.21. The company has a current ratio of 3.35, a quick ratio of 2.91 and a debt-to-equity ratio of 0.03. The business has a 50-day moving average of $36.45 and a 200 day moving average of $34.97. The stock has a market capitalization of $2.03 billion, a price-to-earnings ratio of 40.61 and a beta of 0.94.
Analysts Set New Price Targets
Several brokerages have weighed in on VITL. Telsey Advisory Group upped their price objective on shares of Vital Farms from $46.00 to $50.00 and gave the stock an "outperform" rating in a research note on Friday. BMO Capital Markets reaffirmed an "outperform" rating on shares of Vital Farms in a research note on Friday. Mizuho began coverage on shares of Vital Farms in a research note on Tuesday, July 8th. They set an "outperform" rating and a $45.00 price objective on the stock. Morgan Stanley decreased their price objective on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday, April 17th. Finally, Stifel Nicolaus increased their price target on shares of Vital Farms from $44.00 to $48.00 and gave the company a "buy" rating in a research note on Friday. Ten analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of "Buy" and an average price target of $44.89.
Read Our Latest Stock Analysis on VITL
Insider Activity at Vital Farms
In related news, CFO Thilo Wrede sold 1,200 shares of the stock in a transaction that occurred on Friday, July 11th. The shares were sold at an average price of $38.97, for a total value of $46,764.00. Following the transaction, the chief financial officer directly owned 56,187 shares in the company, valued at $2,189,607.39. This represents a 2.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Matthew Ohayer sold 5,000 shares of the stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $40.34, for a total transaction of $201,700.00. Following the completion of the transaction, the insider owned 6,872,070 shares in the company, valued at $277,219,303.80. This represents a 0.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 67,400 shares of company stock worth $2,413,630 over the last three months. 21.30% of the stock is owned by insiders.
Hedge Funds Weigh In On Vital Farms
Several large investors have recently bought and sold shares of VITL. Royal Bank of Canada lifted its holdings in Vital Farms by 89.2% in the first quarter. Royal Bank of Canada now owns 19,381 shares of the company's stock valued at $591,000 after buying an additional 9,136 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Vital Farms by 5.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 20,057 shares of the company's stock valued at $611,000 after buying an additional 1,108 shares during the period. Cetera Investment Advisers lifted its holdings in Vital Farms by 76.9% in the second quarter. Cetera Investment Advisers now owns 19,338 shares of the company's stock valued at $745,000 after buying an additional 8,405 shares during the period. Woodline Partners LP acquired a new position in Vital Farms in the first quarter valued at approximately $1,073,000. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Vital Farms by 1.4% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 89,893 shares of the company's stock valued at $2,739,000 after buying an additional 1,198 shares during the period. 98.59% of the stock is currently owned by institutional investors and hedge funds.
Vital Farms Company Profile
(
Get Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.